DISCRETE EVENT SIMULATION FOR COVID-19 DRIVE-THROUGH MASS VACCINE DISTRIBUTION EVENTS

被引:0
|
作者
Ema, Sajia Afrin [1 ]
Hossain, Sayed Kaes Maruf [1 ]
Sohn, Christine [1 ,2 ]
Sohn, Hansuk [1 ]
机构
[1] New Mexico State Univ, Dept Ind Engn, Las Cruces, NM 88003 USA
[2] Univ Calif Los Angeles, Dept Int Dev Studies, Los Angeles, CA USA
关键词
Discrete Event Simulation; COVID-19; Drive-through Site; Mass Vaccination; Simulation Optimization; OPTIMIZATION; MODEL;
D O I
10.23055/ijietap.2024.31.4.8441
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
The key aim of this research is to demonstrate how a discrete-event simulation model and the simulation-based optimization model could help organizers of the mass vaccination distribution site better understand the system dynamics and make effective data-driven decisions. The proposed simulation model was developed based on empirical data collected during the COVID-19 drive-through vaccination events and insights provided by the system experts. Both the simulation and the simulation-based optimization models are found to be effective in helping the COVID-19 drive-through events' decision- makers by providing information on how their system would respond over time under various scenarios leading to more informed and systematic decisions about the process and resource management. The model could easily be extended and reused for any other drive-through mass vaccination facilities in the future.
引用
收藏
页码:872 / 889
页数:18
相关论文
共 50 条
  • [41] The ethics of COVID-19 vaccine distribution
    Nichol, Ariadne A.
    Mermin-Bunnell, Kellen M.
    JOURNAL OF PUBLIC HEALTH POLICY, 2021, 42 (03) : 514 - 517
  • [42] Signaling COVID-19 Vaccine Adverse Events
    Rave Harpaz
    William DuMouchel
    Robbert Van Manen
    Alexander Nip
    Steve Bright
    Ana Szarfman
    Joseph Tonning
    Magnus Lerch
    Drug Safety, 2022, 45 : 765 - 780
  • [43] Signaling COVID-19 Vaccine Adverse Events
    Harpaz, Rave
    DuMouchel, William
    Van Manen, Robbert
    Nip, Alexander
    Bright, Steve
    Szarfman, Ana
    Tonning, Joseph
    Lerch, Magnus
    DRUG SAFETY, 2022, 45 (07) : 765 - 780
  • [44] OVERVIEW OF COVID-19 VACCINE ADVERSE EVENTS
    Dobrek, Lukasz
    ACTA POLONIAE PHARMACEUTICA, 2024, 81 (04): : 577 - 601
  • [45] Vaccine drive against Covid-19 starts in India
    Shrivastava, Jyoti Priyadarshini
    NATIONAL MEDICAL JOURNAL OF INDIA, 2021, 34 (02): : 125 - 125
  • [46] Drive-through point-of-care INR testing: Novel concepts for delivery of care during the COVID-19 pandemic
    Peduzzi, Bradley
    Hill, Marilyn Gaske
    Hamilton, Janet
    Parker, Courtney
    Raut, Sukriti
    Berndsen, Joseph
    Farrell, Courtney
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (01) : E4 - E7
  • [47] Audit of outcomes following attendance at the City West drive-through IOP glaucoma clinic during the COVID-19 pandemic
    Powell, Sarah
    Doolan, Emer
    Curtin, Karen
    Doyle, Aoife
    O'Brien, Colm
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 (06) : 2813 - 2822
  • [48] Implementation of a drive-through/courier service for collecting oral anti-cancer medicines in response to the COVID-19 pandemic
    Patel, Tahir
    Yew, Lai Cheng
    CLINICAL ONCOLOGY, 2022, 34 : E9 - E10
  • [49] The implementation of an active surveillance integrating information technology and drive-through coronavirus testing station for suspected COVID-19 cases
    Chen, Hung-Jui
    Lin, Hung-Jung
    Wu, Mei-Chen
    Tang, Hung-Jen
    Su, Bo-An
    Lai, Chih-Cheng
    JOURNAL OF INFECTION, 2021, 82 (02) : 304 - 306
  • [50] Fractured aluminum nasopharyngeal swab during drive-through testing for COVID-19: radiographic detection of a retained foreign body
    Azar, Antoine
    Wessell, Daniel E.
    Janus, Jeffrey R.
    Simon, Leslie, V
    SKELETAL RADIOLOGY, 2020, 49 (11) : 1873 - 1877